Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) COO John Gallagher sold 3,604 shares of the business’s stock in a transaction that occurred on Friday, August 28th. The shares were sold at an average price of $29.70, for a total value of $107,038.80. Following the completion of the sale, the chief operating officer owned 33,742 shares of the company’s stock, valued at $1,002,137.40. The trade was a 9.65% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Trupanion Stock Up 1.9%
Shares of NASDAQ:TRUP opened at $28.79 on Friday. The business’s 50 day moving average is $27.39 and its 200 day moving average is $25.87. The stock has a market cap of $1.26 billion, a P/E ratio of 54.32, a price-to-earnings-growth ratio of 1.91 and a beta of 1.45. Trupanion, Inc. has a 52-week low of $21.16 and a 52-week high of $46.98. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.24.
Trupanion (NASDAQ:TRUP – Get Free Report) last issued its earnings results on Wednesday, August 5th. The financial services provider reported $0.16 earnings per share for the quarter, beating analysts’ consensus estimates of $0.11 by $0.05. Trupanion had a return on equity of 5.96% and a net margin of 1.53%.The business had revenue of $392.93 million during the quarter, compared to analyst estimates of $389.72 million. During the same period in the previous year, the company posted $0.22 EPS. Trupanion’s revenue was up 11.1% on a year-over-year basis. Sell-side analysts predict that Trupanion, Inc. will post 0.63 EPS for the current year.
Institutional Investors Weigh In On Trupanion
Analyst Upgrades and Downgrades
A number of analysts recently weighed in on the stock. Stifel Nicolaus upped their price objective on shares of Trupanion from $28.00 to $29.00 and gave the stock a “hold” rating in a research note on Thursday, August 20th. Piper Sandler downgraded shares of Trupanion from an “overweight” rating to a “neutral” rating and cut their target price for the company from $45.00 to $32.00 in a research report on Wednesday, August 26th. Zacks Research lowered shares of Trupanion from a “strong-buy” rating to a “hold” rating in a report on Monday, August 24th. Atlantic Securities set a $42.00 price target on shares of Trupanion in a research report on Wednesday, July 15th. Finally, Weiss Ratings upgraded shares of Trupanion from a “hold (c-)” rating to a “hold (c)” rating in a research note on Wednesday, August 26th. One investment analyst has rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, Trupanion currently has an average rating of “Hold” and a consensus target price of $39.20.
Get Our Latest Analysis on TRUP
Trupanion Company Profile
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
Featured Stories
- Five stocks we like better than Trupanion
- The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story
- NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now
- Dropping the Dough: Yum! Brands Strategically Trims the Fat
- These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
